SMAD7 targeting program (WaVe Life Sciences)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSMAD7 targeting program (WaVe Life Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMothers against decapentaplegic homolog 7 inhibitors
TargetsMothers against decapentaplegic homolog 7
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWave Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWave Life Sciences Ltd
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A